BACKGROUND: Recently, miR-378 has been shown to modulate the anti-hypoxia capacity of bone marrow mesenchymal stem cells (BMSCs) and reduce cell apoptosis under hypoxic conditions.
OBJECTIVE: To investigate the benefits of miR-378-upregulated BMSC transplantation in a rat model of acute myocardial infarction.
METHODS:Primary rat BMSCs were cultured in vitro. Until passage 3, the cells were infected with the lentivirus carrying synthetic miR-378 gene fragments. A rat model for acute myocardial infarction was constructed by ligating the left anterior descending artery. Thereafter, the animals were randomly assigned to three groups: control group (n=10), BMSCnull group (n=16) and BMSCmiR-378 group (n=16). In the latter two groups, 50 μL of normal saline containing 1×107 empty virus-transfected or miR-378-transfected BMSCs was injected into the region of myocardial infarction, respectively. Only 50 μL of normal saline was injected in the control group. Twenty-four hours later, the apoptosis of transplanted BMSCs was evaluated with TUNEL, and expression level of vascular endothelial growth factor and transforming growth factor-β was detected using western blot assay. Four weeks after treatment, the left ventricular function of rats was assessed by echocardiography, and then histological and molecular biology analyses were performed.
RESULTS AND CONCLUSION: At 24 hours postoperatively, there were less apoptotic BMSCs and higher expression levels of vascular endothelial growth factor and transforming growth factor-β in the BMSCmiR-378 group than in the BMSCnull group (n=6, P < 0.001). Four weeks later, there were more transplanted BMSCs and BMSCs-derived cardiomyocytes in the BMSCmiR-378 group than the BMSCnull group (n=10, P < 0.001). Moreover, increased new vessel density (P < 0.001), decreased infarcted area (P < 0.001), preserved left ventricular ejection fraction (P < 0.05), reduced left ventricular end-diastolic volume (P < 0.05) were found in the BMSCmiR-378 group, compared with the other two groups. The above parameters were better in the BMSCnull group than the control group (P < 0.05). Overall, the upregulation of miR-378 could enhance the capability of BMSCs against hypoxia, and consequently promote myocardial repair after implantation, providing a new strategy for cell therapy of myocardial infarction.
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程